Available Technologies

Filter

Results

Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-Negative Breast Cancer

Technology / Case number: #16742
Linda Griffith / Madeleine Oudin / Miles Miller / Aaron Meyer / Frank Gertler / Douglas Lauffenburger
Technology Areas: Therapeutics
Impact Areas: Healthy Living
Labels
  • Women's Health
License

Synthesis and Anticancer Activity of Agelastatin Alkaloids

Technology / Case number: #16512J
Mo Movassaghi / Paul Hergenrother
Technology Areas: Therapeutics
Impact Areas: Healthy Living
Labels
  • Women's Health
License

An Oxaliplatin Crosslinker for the Formation of Drug Delivery Nanoparticles

Technology / Case number: #17532
Jeremiah A. Johnson / Jonathan Barnes / Longyan Liao
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living, Uncharted Frontiers, Advanced Materials
Labels
  • Women's Health
License

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 3 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up